BioAffinity Technologies Inc (NASDAQ: BIAF) on Friday, soared 55.13% from the previous trading day, before settling in for the closing price of $3.41. Within the past 52 weeks, BIAF’s price has moved between $3.40 and $67.12.
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -10.71%. The company achieved an average annual earnings per share of 36.00%. With a float of $0.97 million, this company’s outstanding shares have now reached $1.34 million.
BioAffinity Technologies Inc (BIAF) Breakdown of a Key Holders of the stock
Observing investor behavior towards Diagnostics & Research industry stocks is more important than anything else. The insider ownership of BioAffinity Technologies Inc is 27.44%, while institutional ownership is 1.04%.
BioAffinity Technologies Inc (BIAF) Recent Fiscal highlights
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -4.8 earnings per share (EPS) for the period falling under the consensus outlook (set at -4.5) by -0.3. Wall Street market experts anticipate that the next fiscal year will bring earnings of -2.7 per share during the current fiscal year. According to the Wall Street analysts, stocks earnings will be around 36.00% per share during the next fiscal year.
BioAffinity Technologies Inc (NASDAQ: BIAF) Trading Performance Indicators
BioAffinity Technologies Inc (BIAF) is currently performing well based on its current performance indicators. A quick ratio of 0.63 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.92.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -20.98, a number that is poised to hit -2.70 in the next quarter and is forecasted to reach -8.10 in one year’s time.
Technical Analysis of BioAffinity Technologies Inc (BIAF)
Compared to the last year’s volume of 0.79 million, its volume of 20.18 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 11.76%.
During the past 100 days, BioAffinity Technologies Inc’s (BIAF) raw stochastic average was set at 16.29%, which indicates a significant decrease from 18.71% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.26 in the past 14 days, which was higher than the 1.13 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.86, while its 200-day Moving Average is $13.90. Nevertheless, the first resistance level for the watch stands at $6.84 in the near term. At $8.38, the stock is likely to face the second major resistance level. The third major resistance level sits at $9.48. If the price goes on to break the first support level at $4.20, it is likely to go to the next support level at $3.10. Now, if the price goes above the second support level, the third support stands at $1.56.
BioAffinity Technologies Inc (NASDAQ: BIAF) Key Stats
Market capitalization of the company is 7.08 million based on 985K outstanding shares. Right now, sales total 9,360 K and income totals -9,040 K. The company made 1,270 K in profit during its latest quarter, and -4,060 K in sales during its previous quarter.
